Furthermore, we have identified three genes implicated in cancer metastasis – MMP13, ST6GAL2, and ENPP1, which pazopanib has demonstrated to downregulate in our study and could act as drug-response biomarkers or a druggable target with regards to the latter. This evidence concerns the gene MMP13 and cancer.